title: Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats.
abstract: The present study was aimed at answering the question why feeding rats an oligofructose (OFS) supplemented diet could cause a significant reduction in plasma lipid levels. Daily administration of a 10% (w/w) OFS-containing diet to normolipidemic male rats resulted in a decrease in plasma triglycerides, phospholipids and cholesterol. The triglyceride-lowering effect was observed after one week and lasted for at least 16 wk and was associated with a reduction in plasma very low density lipoproteins, indicating that the hypolipidemic effect of OFS may be due to changes in liver lipid metabolism. We therefore tested whether OFS feeding modified the capacity of the liver to synthesize triglycerides from free fatty acids. Hepatocytes isolated from livers of control and OFS-fed rats were incubated in the presence of [1-14C]palmitate, and both intracellular and extracellular [14C]triglyceride formation were quantified. We found that chronic feeding of an OFS-supplemented diet to rats significantly reduced the capacity of isolated hepatocytes to synthesize triglycerides from palmitate. The results suggest that, like other soluble dietary fibers, OFS significantly alters liver lipid metabolism, resulting over time in a significant reduction in plasma triglyceride, phospholipid and cholesterol levels.
authors.affiliation: Départment des Sciences Pharmaceutiques, Faculté de Médecine, Université Catholique de Louvain, Brussels, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Fiordaliso
authors.forename: N
authors.initials: N
authors.lastname: Kok
authors.forename: J P
authors.initials: JP
authors.lastname: Desager
authors.forename: F
authors.initials: F
authors.lastname: Goethals
authors.forename: D
authors.initials: D
authors.lastname: Deboyser
authors.forename: M
authors.initials: M
authors.lastname: Roberfroid
authors.forename: N
authors.initials: N
authors.lastname: Delzenne
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D003066:Coenzyme A Ligases / Q000378:metabolism; D004040:Dietary Carbohydrates / Q000494:pharmacology*; D004435:Eating / Q000502:physiology; D005632:Fructose / Q000737:chemistry*; D008055:Lipids / Q000097:blood*; D008079:Lipoproteins, VLDL / Q000097:blood; D008099:Liver / Q000166:cytology / Q000502:physiology; D008297:Male; D009844:Oligosaccharides / Q000737:chemistry / Q000494:pharmacology*; D010743:Phospholipids / Q000097:blood; D051381:Rats; D017208:Rats, Wistar; D012097:Repressor Proteins; D029701:Saccharomyces cerevisiae Proteins; D014280:Triglycerides / Q000097:blood; D015430:Weight Gain / Q000502:physiology; D000098859:Long-Chain-Fatty-Acid-CoA Ligase
chemical_list: D004040:Dietary Carbohydrates; D008055:Lipids; D008079:Lipoproteins, VLDL; D009844:Oligosaccharides; D010743:Phospholipids; D012097:Repressor Proteins; D029701:Saccharomyces cerevisiae Proteins; D014280:Triglycerides; D005632:Fructose; D003066:Coenzyme A Ligases; C090799:FAA2 protein, S cerevisiae; D000098859:Long-Chain-Fatty-Acid-CoA Ligase